CardioPulmonary Resuscitation With Argon (CPAr) Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT05482945
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Registry
-
NCT05482945
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT05482945. Randomized; single masking; primary purpose treatment. Start 2022-05-30 (actual); primary completion 2026-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CardioPulmonary Resuscitation With Argon (CPAr) Trial
- Acronym
- CPAr
- Condition
- Cardiac Arrest, Out-Of-Hospital
- Condition
- Cardiac Arrest With Successful Resuscitation
- Intervention (Drug)
- Noble gas Argon
- Lead sponsor
- Mario Negri Institute for Pharmacological Research
Record details
- Record id
cardio:ct-nct05482945- Content hash
6449b12bc3666bf9ef195cdd6d6531aaed510eb799bef4da99393a7264571747